Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

86.18

-1.18 (-1.35%)

Nov 28, 2025, 1:00 PM EST - Market closed

Monopar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Nov '25 Nov 28, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	576	134	5	31	40	70	Upgrade
Market Cap Growth	532.57%	2552.79%	-83.48%	-24.23%	-42.34%	-59.48%	Upgrade
Enterprise Value	432	128	-3	16	18	52	Upgrade
Last Close Price	86.18	22.00	1.70	11.85	16.05	30.60	Upgrade
PB Ratio	4.06	2.44	0.91	3.04	2.13	4.47	Upgrade
P/TBV Ratio	4.07	2.44	0.91	3.04	2.13	4.47	Upgrade
Debt / Equity Ratio	0.00	-	-	0.00	-	-	Upgrade
Quick Ratio	55.94	11.46	4.14	4.19	12.85	14.22	Upgrade
Current Ratio	56.10	11.48	4.17	4.21	12.98	14.28	Upgrade
Return on Equity (ROE)	-26.54%	-51.42%	-107.19%	-72.45%	-52.57%	-44.52%	Upgrade
Return on Assets (ROA)	-17.99%	-29.87%	-53.66%	-39.03%	-30.51%	-26.92%	Upgrade
Return on Capital (ROIC)	-18.44%	-33.32%	-70.38%	-45.36%	-32.94%	-28.73%	Upgrade
Return on Capital Employed (ROCE)	-15.30%	-29.40%	-158.00%	-104.30%	-48.20%	-41.50%	Upgrade
Earnings Yield	-3.38%	-11.62%	-166.13%	-34.34%	-22.52%	-9.00%	Upgrade
Buyback Yield / Dilution	-97.28%	-37.09%	-8.70%	-1.97%	-13.82%	-17.56%	Upgrade

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q